✦ LIBER ✦

Combining an EGFR directed tyrosine kinase inhibitor with autophagy-inducing drugs: A beneficial strategy to combat non-small cell lung cancer

✍ Scribed by Yaara Gorzalczany; Yuval Gilad; Dina Amihai; Ilan Hammel; Ronit Sagi-Eisenberg; Ofer Merimsky

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Primary resistance to epidermal growth f

✍ Lee, J. K.; Shin, J.- Y.; Kim, S.; Lee, S.; Park, C.; Kim, J.- Y.; Koh, Y.; Keam 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 215 KB

Survivin mRNA expression in blood as a p

✍ Shi, Wei-Lin; Li, Jian; Bao, Quan-Lei; Wu, Jian-Nong; Ge, Li-Ping; Zhu, Li-Rong; 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 514 KB

BMS-690514, a VEGFR and EGFR tyrosine ki

✍ Loriot, Y; Mordant, P; Dorvault, N; De la motte Rouge, T; Bourhis, J; Soria, J-C 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 464 KB

ZD1839, a selective epidermal growth fac

✍ David Raben; Barbara A. Helfrich; Dan Chan; Gary Johnson; Paul A. Bunn Jr 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Pilot trial of ZD1839 (IressaTM), an ora

✍ Laurie, S.A; Miller, V.A; Johnson, D; Ng, K.K; Heelan, R.T; Pizzo, B.A; Perez, W 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB

A phase I and pharmacokinetic study of d

✍ Glenwood Goss; Frances A. Shepherd; Scott Laurie; Isabelle Gauthier; N. Leighl; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 137 KB